Arsenal Capital Partners today completed the previously announced sale of its portfolio company Flowchem, a leading manufacturer of pipeline performance products, to KMG, a global provider of specialty chemicals, for $495 million.
KMG, a global provider of specialty chemicals, today announced it has signed a definitive agreement to acquire Flowchem, a leading manufacturer of pipeline performance products, from Arsenal Capital Partners (Arsenal).
Accella Polyurethane Systems LLC has agreed to purchase certain assets of the North American spray polyurethane foam (SPF) business from Covestro LLC. The sale is scheduled to be completed by April 1, 2017. Financial terms have not been disclosed.
Salley Most Recently Served as Chief Executive Officer of Milliken & Company
NEW YORK, January 24, 2017 — Arsenal Capital Partners, a leading New York based private equity firm that invests in middle market specialty industrials and healthcare companies, announced today that it has expanded its team with the addition of Joseph M. Salley, former Chief Executive Officer of Milliken & Company, as an Operating Partner working within the firm’s Specialty Industrials Group.
Arsenal Capital Partners is a specialized private equity firm that invests in the U.S. middle market with a narrow and deep focus in two sectors, Specialty Industrials and Healthcare. Our philosophy is to partner with talented management teams, provide them with access to world-class operating resources and patient capital, and develop positive, open and constructive relationships that foster long-term value creation.